P3.13-28 Heterogeneity, Prevalence and Prognostic Significance of PDL1 Expression in Early Resected NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1869
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Significance of Twist and N-Cadherin Expression in NSCLC

PLoS ONE
Multidisciplinary
2013English

Prognostic Significance of IMMT Expression in Surgically‐resected Lung Adenocarcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Prognostic Significance of XB130 Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma

World Journal of Surgical Oncology
SurgeryOncology
2014English

MicroRNA Expression and Outcome in Resected NSCLC--Letter

Cancer Research
Cancer ResearchOncology
2011English

Clinicopathological and Prognostic Significance of Twist Overexpression in NSCLC

Oncotarget
Oncology
2018English

Expression and Prognostic Significance of Cyclin‑dependent Kinase Inhibitor 1A in Patients With Resected Gastric Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2017English

P3.04-15 IDO and Tim3 Gene Expression Is Correlated in NSCLC Patients With Low PDL1 Gene Expression

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.04-28 Can Ipilimumab Restore Immune Response in Advanced NSCLC After Progression on Anti PD1/PDL1 Agents?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prevalence and Prognostic Significance of Neuroendocrine Cells in Esophageal Adenocarcinoma

Modern Pathology
Forensic MedicinePathology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy